|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
2014 Legislative Summary
The Florida Legislature adjourned Sine Die on Friday, May 2 at 10:40 p.m. The Florida Society of Patholologists fought many issues backed by big business (Associated Industries of Florida, Florida Chamber of Commerce, et.al) as well as the insurance lobby but we succeeded once again in killing all proposals that would have been detrimental to pathologists in Florida.
Amy Young, FSP Lobbyist
FSP 2014 Summer Anatomic Pathology Conference
|Geza Acs, MD, PhD
Ruffolo, Hooper & Associates,
Teri A. Longacre, MD
Stanford University Medical Center
Anatomic Pathology Department,
Bruce R. Smoller, MD
University of Arkansas for Medical
Pathology, Little Rock, AR
Registration is now open at www.flpath.org for the 2014 Florida Society of Pathologists Summer Anatomic Pathology Conference. The summer conference is always an excellent combination of education, CMEs and family beach fun! Don't be left out this year. We have an amazing faculty as well as unique networking opportunities. Our vendors will be present showcasing the latest in products and services. Please be sure to go to www.flpath.org and register. The meeting will be held at The Breakers in Palm Beach, Florida. Hotel reservations can be made online by visiting https://resweb.passkey.com/go/FSP14. The FSP discounted group rate is $205 single/double.
Brief formalin fixation and rapid tissue processing do not affect the sensitivity of ER immunohistochemistry of breast core biopsies
American Journal of Clinical Pathology via Medscape
The decision to initiate treatment for patients with breast cancer is based on the results of tissue biomarker studies including estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2. Breast core needle biopsy specimens are now the primary source for the performance of these tests, particularly if neoadjuvant therapy is being considered. Preanalytic variables may affect the accuracy of ER, PR, and HER2 results.
Scientists identify 'high-priority' chemicals that may cause breast cancer
Medical News Today
An estimated 12.4 percent of women born in the U.S. today will develop breast cancer at some point during their lives. Past research has indicated that exposure to some chemicals may increase the risk of breast cancer. Now, a new study has identified 17 "high-priority" chemicals women should avoid in order to reduce such risk and demonstrates how their presence can be detected.
Mighty Y chromosome is full of surprises
The Y chromosome has always been the runt of the genetic litter. Usually relegated to the bottom row on genetic plots; scientists believed its main function was to make us male instead of female. Now, they're discovering it does a whole lot more.
Sorry, medical students, but you're not entitled to your dream job
The process of matching graduating medical school seniors with residency programs attempts to satisfy the desires of trainees and programs, with the goal of ultimately benefiting patients. In a recent piece, medical student Amy Ho listed several complaints with the current process of matching residency applicants with programs. In fact, she believes the National Resident Matching Program and the Main Residency Match ought to be done away with altogether.
Significant number of primary care doctors uncertain about the correct clinical lab test to order
Recent publication of a new study confirms what pathologists and medical laboratory professionals have known for years: a significant number of primary care physicians acknowledge that they sometimes are uncertain about which clinical laboratory test is the most appropriate one to order. These same doctors also admit that they are often also uncertain how to interpret the results of some medical laboratory tests.
2 genes together drive aggressive prostate cancer
The two genes — FOXM1 and CENPF — had been previously implicated in cancer, but none of the prior studies suggested that they might work synergistically to cause the most aggressive form of prostate cancer. The study was published in the online issue of Cancer Cell.
CMS issues final rule recognizing telehealth for Medicare providers
CMS issued a final rule that recognizes the benefits telehealth technologies have to offer Medicare hospitals and providers in remote areas, Modern Healthcare reports. The new regulation — which aims to reduce unnecessary, obsolete or overly burdensome Medicare regulations for hospitals and other providers — stems from an executive order that President Barack Obama issued in 2012.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063